LTRN
Lantern Pharma Inc
1.40$
+2.2%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1,094.2% | +1.9% | +2.5% | -90.5% | +1,067.1% | -91.1% | -1.6% | -8.9% | +0.0% | -6.1% | -2.6% | – | |
| – | -20.9% | -11.1% | +0.1% | +33.5% | +59.3% | -48.2% | +8.7% | -10.5% | +38.4% | +32.2% | +8.5% | – | |
| – | – | +142.4% | -114.2% | – | – | -94.7% | +452.7% | -272.0% | – | -190.8% | – | – | |
| – | +6.4% | -56.4% | +92.5% | -29.0% | +1.8% | -62.4% | -99.7% | +18,566.7% | -99.8% | +200.0% | -100.0% | – | |
| – | +10.6% | -317.1% | -63.7% | – | +406.7% | -6.0% | +10.9% | +65.0% | -128.7% | – | -83.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -100.0% | – | -100.0% | – | -100.0% | – | -45.8% | – | – | – | |
| – | – | – | – | – | – | – | – | – | -270.4% | – | +252.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.